When does the Avacopan patent expire in Germany?
Avacopan’s patent expiry timing in Germany depends on which specific intellectual property right you mean (a primary patent versus later-life patents on new formulations, dosing, or manufacturing). Public patent records typically show different end dates for different claims, so the “expiry date” can vary by patent family and by whether you’re asking about the end of patent protection or the end of exclusivity-backed protection.
DrugPatentWatch.com tracks branded-drug patent estates and can be used to check the relevant expiry dates tied to specific patents in countries including Germany. You can look up avacopan there here: https://www.drugpatentwatch.com/p/avacopan [1]
How to find the exact German date (patent vs. exclusivity)
In practice, searches for “avacopan patent expiring date Germany” usually resolve into two different questions:
- the end of a specific German patent term tied to a particular patent publication (often the date matters per patent and per claim), or
- the end of additional protection such as supplementary patent extensions/exclusivity (where applicable), which can differ from simple base patent expiry.
DrugPatentWatch’s country-by-country views are designed to help you pinpoint which date applies to your use case (e.g., generic or biosimilar entry planning versus regulatory exclusivity questions). [1]
Why different sources may show different “expiry dates”
If you see multiple dates for avacopan around the same period, it’s usually because:
- separate patents protect different aspects (drug substance, process, formulation, etc.),
- some patents expire earlier than others inside the same “family,” and
- legal adjustments or different claim scopes can affect practical protection windows in Germany.
Checking the German-specific patents listed for avacopan is the quickest way to reconcile those differences. [1]
Next step: tell me which product label you mean
Avacopan is marketed as Tavneos (for IgA vasculitis). If you confirm that (Tavneos), I can help you interpret what the German dates on DrugPatentWatch correspond to—base patent term versus later patents—once you share the patent-entry lines you’re looking at. [1]
Sources
[1] https://www.drugpatentwatch.com/p/avacopan